#BEGIN_DRUGCARD DB03315

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
28072

# Chemical_Formula:
C10H14N5O8P

# Chemical_IUPAC_Name:
{[(2S,3R,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Guanosine-3'-Monophosphate

# HET_ID:
3GP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-5(17)6(3(1-16)22-9)23-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5+,6-,9+/m0/s1

# InChI_Key:
InChIKey=ZDPUTNZENXVHJC-FULWYAMNSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3315

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
363.2206

# Molecular_Weight_Mono:
363.057998961

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GOY

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2

# Predicted_LogS:
-2

# Predicted_Water_Solubility:
3.51e+00 g/l

# Primary_Accession_No:
DB03315

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6602107

# PubChem_Substance_ID:
46508235

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00169

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC2=C(N=CN2[C@@H]2O[C@@H](CO)[C@H](OP(O)(O)=O)[C@H]2O)C(=O)N1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:08 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U06867

# Drug_Target_1_GenBank_ID_Protein:
532528

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>489 bp
ATGAAAAAAATCAGTTCGGTTTTTACTATGTTTGCTCTGATCGCTGCTATTCTGTTTTCT
GGTTTTATTCCGCAGCAAGCCTATGCCGAAACAACACTTACACCGACCGCCACAAATAAA
ACAGCTTCTATTCAACTGACATCAGATGTTCATACCCTTGCCGTCATTAATACGTTTGAT
GGTGTAGCAGATTATTTAATTCGCTACAAACGACTGCCTGATAACTACATCACAAAATCA
CAAGCAAGTGCTCTTGGATGGGTGGCATCGAAGGGAAATCTAGCAGAGGTTGCCCCAGGC
AAAAGCATCGGTGGAGATGTTTTCTCTAACCGGGAGGGACGTCTTCCTTCAGCAAGCGGC
CGCACATGGCGTGAAGCAGATATCAACTACGTCTCAGGCTTCCGCAATGCTGACCGCCTC
GTGTATTCAAGTGACTGGCTCATTTATAAAACAACAGACCATTATGCGACATTCACACGT
ATTCGATAA

# Drug_Target_1_General_Function:
Involved in RNA binding

# Drug_Target_1_General_References:
8001670	Znamenskaya LV, Gabdrakhmanova LA, Chernokalskaya EB, Leshchinskaya IB, Hartley RW: Phosphate regulation of biosynthesis of extracellular RNases of endospore-forming bacteria. FEBS Lett. 1995 Jan 2;357(1):16-8.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2865

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
17914

# Drug_Target_1_Name:
Ribonuclease

# Drug_Target_1_Number_of_Residues:
162

# Drug_Target_1_PDB_ID:
1BUJ

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00545	Ribonuclease

# Drug_Target_1_Protein_Sequence:
>Ribonuclease precursor
MKKISSVFTMFALIAAILFSGFIPQQAYAETTLTPTATNKTASIQLTSDVHTLAVINTFD
GVADYLIRYKRLPDNYITKSQASALGWVASKGNLAEVAPGKSIGGDVFSNREGRLPSASG
RTWREADINYVSGFRNADRLVYSSDWLIYKTTDHYATFTRIR

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-29

# Drug_Target_1_Specific_Function:
This is a purine-specific ribonuclease

# Drug_Target_1_SwissProt_ID:
P48068

# Drug_Target_1_SwissProt_Name:
RN_BACPU

# Drug_Target_1_Synonyms:
EC 3.1.27.-
RNase Bp
Ribonuclease precursor

# Drug_Target_1_Theoretical_pI:
9.91

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X76083

# Drug_Target_2_GenBank_ID_Protein:
431230

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
pyrR

# Drug_Target_2_Gene_Sequence:
>540 bp
ATGCAAAAGGCGGTCGTGATGGACGAACAGGCGATTCGCCGCGCTTTGACGCGCATCGCC
CACGAAATCATCGAACGAAACAAAGGCATTGACGGCTGCGTGCTTGTCGGAATTAAAACG
CGCGGCATTTACTTGGCGCGCCGCTTGGCGGAGCGGATCGAGCAAATTGAAGGGGCGTCC
GTTCCCGTCGGTGAGCTTGACATCACCTTGTACCGCGACGATTTGACCGTGAAGACGGAC
GACCATGAACCGCTTGTGAAAGGAACGAATGTGCCGTTTCCGGTGACCGAGCGGAATGTC
ATTTTAGTTGATGACGTGCTCTTCACCGGCCGGACGGTGCGGGCGGCGATGGATGCGGTC
ATGGATTTGGGCCGCCCGGCGCGCATCCAGCTCGCCGTGCTTGTTGACCGCGGCCACAGG
GAACTCCCGATCCGCGCTGATTTCGTCGGCAAAAACGTGCCGACCTCTCGTTCGGAACTG
ATCGTCGTGGAGCTTTCGGAAGTGGACGGCATCGATCAAGTCTCCATTCATGAAAAATAG

# Drug_Target_2_General_Function:
Nucleotide transport and metabolism

# Drug_Target_2_General_References:
8206848	Ghim SY, Neuhard J: The pyrimidine biosynthesis operon of the thermophile Bacillus caldolyticus includes genes for uracil phosphoribosyltransferase and uracil permease. J Bacteriol. 1994 Jun;176(12):3698-707.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2966

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
19938

# Drug_Target_2_Name:
PyrR bifunctional protein [Includes: Pyrimidine operon regulatory protein; Uracil phosphoribosyltransferase

# Drug_Target_2_Number_of_Residues:
179

# Drug_Target_2_PDB_ID:
1NON

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00156	Pribosyltran

# Drug_Target_2_Protein_Sequence:
>PyrR bifunctional protein [Includes: Pyrimidine operon regulatory protein; Uracil phosphoribosyltransferase
MQKAVVMDEQAIRRALTRIAHEIIERNKGIDGCVLVGIKTRGIYLARRLAERIEQIEGAS
VPVGELDITLYRDDLTVKTDDHEPLVKGTNVPFPVTERNVILVDDVLFTGRTVRAAMDAV
MDLGRPARIQLAVLVDRGHRELPIRADFVGKNVPTSRSELIVVELSEVDGIDQVSIHEK

# Drug_Target_2_Reaction:
UMP + diphosphate = uracil + 5-phospho-alpha-D-ribose 1-diphosphate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Displays also a weak uracil phosphoribosyltransferase activity which is not physiologically significant

# Drug_Target_2_SwissProt_ID:
P41007

# Drug_Target_2_SwissProt_Name:
PYRR_BACCL

# Drug_Target_2_Synonyms:
EC 2.4.2.9

# Drug_Target_2_Theoretical_pI:
5.71

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03315
